If brain fog significantly impairs daily functioning despite GLP-1 therapy and optimization of other factors, your provider may consider alternative treatment approaches or additional investigations
Morelli M, Blandini F, Simola N, Hauser RA
Incretin-based multi-agonists, such as tirzepatide and retatrutide, target two or more receptors among GLP-1, GIP, and GCGR to enhance insulin secretion, improve fat metabolism, and increase energy expenditureultimately achieving greater weight loss and metabolic improvement
Youre not paying for gimmicks or synthetic fillers
If youre deciding between different protein options, this whey protein vs
Tirzepatide (Mounjaro) for type 2 diabetes starts at 2.5 mg once weekly for four weeks, then increases to 5 mg